,
your personalized virtual assistant to find clinical trials. Go head, 
Lauren K. Colman, MD
St. Francis HospitalFederal Way, Washington - 98003 (253-403-1677) |
- CLINICAL TRIALS 31
- CONDITIONS41
- INTERVENTIONS59
- SINCE1989
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012
Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
June 2010 - February 2013
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
May 2009 - December 2012
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
April 2008 - January 2010
Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
September 2007 - January 2013
Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
December 2008 - June 2010
Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
February 2008 - August 2009
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer
February 2008 - December 2017
Paclitaxel Albumin-Stabilized Nanoparticle Formulation Doxorubicin Cyclophosphamide and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
April 2010 - June 2010
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
June 2003 - April 2011
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma Waldenstrom's Macroglobulinemia Amyloidosis or Monoclonal Gammopathy of Undetermined Significance
November 2003 -
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
March 2005 -
Collecting Analyzing and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
February 1989 -
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
October 2006 - September 2011
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy
September 2009 - January 2012
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
December 2006 - September 2011
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008
Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
March 2007 - November 2011
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
August 2009 - February 2015
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
July 1991 -
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
July 2005 - July 2012
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
April 1999 -
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
May 2005 - March 2010
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
March 2010 - January 2020
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Prostatic Neoplasms
Amyloidosis
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Neoplasm Metastasis
Myelodysplastic Syndromes
Preleukemia
Ovarian Neoplasms
Urinary Bladder Neoplasms
Carcinoma
Fatigue
Carcinoma, Non-Small-Cell Lung
Neurotoxicity Syndromes
Precancerous Conditions
Myeloproliferative Disorders
Sarcoma
Colorectal Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Hematologic Neoplasms
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Waldenstrom Macroglobulinemia
Carcinoma, Ductal, Breast
Carcinoma, Ductal
Monoclonal Gammopathies, Benign
Paraproteinemias
Carcinosarcoma
Placebo
Melphalan
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Rituximab
Zoledronic Acid
Filgrastim
Celecoxib
Study Of Socioeconomic And Demographic Variables
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Dasatinib
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Cyclophosphamide
Prednisone
Ifosfamide
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Oxaliplatin
Doxorubicin Hydrochloride
Etoposide
Vincristine Sulfate
Polymerase Chain Reaction
Bicalutamide
Flutamide
Goserelin
Leuprolide Acetate
Trastuzumab
Lapatinib Ditosylate
Pegfilgrastim
Thalidomide
Fluorescence In Situ Hybridization
Rosuvastatin
Conventional Surgery
Mutation Analysis
Cetuximab
Biologic Sample Preservation Procedure
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Irinotecan Hydrochloride
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Ac Regimen
Cytogenetic Analysis
Chemotherapy
Duloxetine Hydrochloride
Vinorelbine Ditartrate
Iodine I 125
Palladium Pd 103
Acetyl-L-Carnitine Hydrochloride
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique
